{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:38:25Z","timestamp":1699663105068},"reference-count":26,"publisher":"Georg Thieme Verlag KG","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1055\/a-2012-0856","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:37:02Z","timestamp":1699659422000},"page":"1507-1513","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonale Hypertonie bei Lungenerkrankungen und\/oder Hypoxie"],"prefix":"10.1055","volume":"148","author":[{"given":"Ayham","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Klose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"M Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"SD Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1469-7580.2002.00096.x","article-title":"The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?","volume":"201","author":"N Hopkins","year":"2002","journal-title":"J Anat"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2011.08.035","article-title":"Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice","volume":"147","author":"M Seimetz","year":"2011","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?","volume":"198","author":"G Kovacs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"MM Hoeper","year":"2020","journal-title":"J Heart and Lung Transplant"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jacc.2013.04.091","article-title":"Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension","volume":"62","author":"JM Hilde","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"A Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction","volume":"46","author":"G Raghu","year":"2015","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1183\/09031936.00107206","article-title":"Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant","volume":"30","author":"AF Shorr","year":"2007","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"V Cottin","year":"2010","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1378\/chest.120.2.369","article-title":"The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases","volume":"120","author":"R Kessler","year":"2001","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000452957","article-title":"Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?","volume":"93","author":"R Thurnheer","year":"2017","journal-title":"Respiration"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.rmed.2010.05.009","article-title":"Categorization and impact of pulmonary hypertension in patients with advanced COPD","volume":"104","author":"MJ Cuttica","year":"2010","journal-title":"Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2101483","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry","volume":"58","author":"KM Olsson","year":"2021","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s2213-2600(22)00097-2","article-title":"Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis","volume":"10","author":"MM Hoeper","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"128","author":"HF Nadrous","year":"2005","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/circresaha.121.319970","article-title":"Group 3 Pulmonary Hypertension: From Bench to Bedside","volume":"130","author":"N Singh","year":"2022","journal-title":"Circ Res"},{"key":"ref19","volume-title":"Pulmonary hypertension due to lung disease","author":"CF Barnett","year":"2016","edition":"6th ed"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"I Blanco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"W Seeger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease","volume":"384","author":"A Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"DA Zisman","year":"2010","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s2213-2600(14)70013-x","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"AR Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/s2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"SD Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"TJ Corte","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2012-0856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:38:05Z","timestamp":1699659485000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2012-0856"}},"subtitle":["Pathophysiologie, Diagnose, Prognose und Behandlung"],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2012-0856","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}